Literature DB >> 15910487

Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis.

Sue C Eng1, Shari L Taylor, Victoria Reyes, Stuart Raaka, Jose Berger, Kris V Kowdley.   

Abstract

BACKGROUND: End-stage cirrhosis in the absence of hereditary hemochromatosis (HHC) can be associated with moderate to marked hepatic iron overload, especially in liver disease as a result of alcohol and/or hepatitis C. However, no published studies have addressed extrahepatic iron deposition in this setting.
METHOD: A retrospective case series from three autopsied patients who died from end-stage cirrhosis associated with significant hepatic iron overload. Histology of vital organs was performed to detect extrahepatic iron deposition. HFE genotyping for the C282Y and H63D mutations was determined from archival tissue. Hepatic iron index and hepatic iron concentration (HIC) were quantified from formalin-fixed, paraffin-embedded tissue. Medical records were reviewed for possible causes of iron overload.
RESULTS: Two patients were H63D heterozygous (H63D +/-) and one was wild type (C282Y -/-, H63D -/-). Histology revealed evidence of stainable iron in the heart and pancreas of all three subjects. Additionally, stainable iron was seen in the stomach in one subject and in the thyroid, pituitary, choroid plexus and testes in another subject. HIC ranged from 4354 to 6834 microg/g dry weight and HII from 1.8 to 2.2 (micromol/g/years).
CONCLUSION: Iron overload secondary to end-stage liver disease can be associated with iron deposition in other organs in the absence of HFE-1 HHC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15910487     DOI: 10.1111/j.1478-3231.2005.01004.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Extensive myocardial iron deposition in a patient with hepatitis C.

Authors:  Arthur Rusovici; Samia Ibrahim; Sunita Sood; James Maher; Christine Gerula; Edo Kaluski; Marc Klapholz
Journal:  Tex Heart Inst J       Date:  2012

Review 2.  Metal toxicity, liver disease and neurodegeneration.

Authors:  Roger F Butterworth
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

3.  Comparison of changes in gene expression of transferrin receptor-1 and other iron-regulatory proteins in rat liver and brain during acute-phase response.

Authors:  Ihtzaz Ahmed Malik; Naila Naz; Nadeem Sheikh; Sajjad Khan; Federico Moriconi; Martina Blaschke; Giuliano Ramadori
Journal:  Cell Tissue Res       Date:  2011-03-26       Impact factor: 5.249

4.  Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.

Authors:  Laurent Spahr; Laura Rubbia-Brandt; Muriel Genevay; Antoine Hadengue; Emiliano Giostra
Journal:  BMC Gastroenterol       Date:  2011-10-28       Impact factor: 3.067

5.  Cardiac failure after liver transplantation requiring a biventricular assist device.

Authors:  Rita Jermyn; Eiei Soe; David D'Alessandro; Julia Shin; William Jakobleff; Daniel Schwartz; Milan Kinkhabwala; Paul J Gaglio
Journal:  Case Rep Transplant       Date:  2014-11-09

6.  Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.

Authors:  David Tornai; Peter Antal-Szalmas; Tamas Tornai; Maria Papp; Istvan Tornai; Nora Sipeki; Tamas Janka; Boglarka Balogh; Zsuzsanna Vitalis
Journal:  BMC Gastroenterol       Date:  2021-03-02       Impact factor: 3.067

7.  Decreased serum hepcidin concentration correlates with brain iron deposition in patients with HBV-related cirrhosis.

Authors:  Dong Lin; Jing Ding; Jian-Ying Liu; Yi-Feng He; Zhi Dai; Cai-Zhong Chen; Wei-Zhong Cheng; Jian Zhou; Xin Wang
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Iron accumulation in the choroid plexus, ependymal cells and CNS parenchyma in a rat strain with low-grade haemolysis of fragile macrocytic red blood cells.

Authors:  Isabella Wimmer; Cornelia Scharler; Taro Kadowaki; Sophie Hillebrand; Barbara Scheiber-Mojdehkar; Shuichi Ueda; Monika Bradl; Thomas Berger; Hans Lassmann; Simon Hametner
Journal:  Brain Pathol       Date:  2021-01-29       Impact factor: 6.508

9.  Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes.

Authors:  Sara M Lewin; Kimberly Kallianos; M Ilan Nevah; Susan Zhao; Oren K Fix; Gabriel C Brooks; Teresa De Marco; Atif N Qasim; Karen G Ordovas; Neil Mehta
Journal:  Transplant Direct       Date:  2018-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.